MicroRNA-Attenuated Virus Vaccines
Abstract
:1. Introduction
2. MicroRNA-Attenuated Vaccines
2.1. Mechanisms of MicroRNA Targeting of Viruses
2.2. Species-, Tissue-, and Cell-Specific MicroRNA Targeting of Viruses
2.3. Immunogenicity of MicroRNA-Attenuated Viruses
2.4. Escape from MicroRNA Targeting
2.5. Viral Suppressors of MicroRNAs
3. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Bartel, D.P. Metazoan MicroRNAs. Cell 2018, 173, 20–51. [Google Scholar] [CrossRef] [PubMed]
- Szittya, G.; Burgyan, J. RNA interference-mediated intrinsic antiviral immunity in plants. In Intrinsic Immunity; Cullen, B., Ed.; Springer: Berlin/Heidelberg, Germany, 2013; Volume 371, pp. 153–181. [Google Scholar]
- Nayak, A.; Tassetto, M.; Kunitomi, M.; Andino, R. RNA interference-mediated intrinsic antiviral immunity in invertebrates. In Intrinsic Immunity; Cullen, B., Ed.; Springer: Berlin/Heidelberg, Germany, 2013; Volume 371, pp. 183–200. [Google Scholar]
- Parameswaran, P.; Sklan, E.; Wilkins, C.; Burgon, T.; Samuel, M.A.; Lu, R.; Ansel, K.M.; Heissmeyer, V.; Einav, S.; Jackson, W.; et al. Six RNA viruses and forty-one hosts: Viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog. 2010, 6, e1000764. [Google Scholar] [CrossRef] [PubMed]
- tenOever, B.R. Questioning antiviral RNAi in mammals. Nat. Microbiol. 2017, 2, 17052. [Google Scholar] [CrossRef] [PubMed]
- Cullen, B.R.; Cherry, S.; tenOever, B.R. Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 2013, 14, 374–378. [Google Scholar] [CrossRef] [PubMed]
- Zeng, Y.; Yi, R.; Cullen, B.R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. USA 2003, 100, 9779–9784. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kelly, E.J.; Hadac, E.M.; Greiner, S.; Russell, S.J. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 2008, 14, 1278–1283. [Google Scholar] [CrossRef] [PubMed]
- Kelly, E.J.; Nace, R.; Barber, G.N.; Russell, S.J. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J. Virol. 2010, 84, 1550–1562. [Google Scholar] [CrossRef] [PubMed]
- Ruiz, A.J.; Hadac, E.M.; Nace, R.A.; Russell, S.J. MicroRNA-detargeted mengovirus for oncolytic virotherapy. J. Virol. 2016, 90, 4078–4092. [Google Scholar] [CrossRef] [PubMed]
- Edge, R.E.; Falls, T.J.; Brown, C.W.; Lichty, B.D.; Atkins, H.; Bell, J.C. A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol. Ther. 2008, 16, 1437–1443. [Google Scholar] [CrossRef] [PubMed]
- Brown, B.D.; Venneri, M.A.; Zingale, A.; Sergi Sergi, L.; Naldini, L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 2006, 12, 585–591. [Google Scholar] [CrossRef] [PubMed]
- Suzuki, T.; Sakurai, F.; Nakamura, S.; Kouyama, E.; Kawabata, K.; Kondoh, M.; Yagi, K.; Mizuguchi, H. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy. Mol. Ther. 2008, 16, 1719–1726. [Google Scholar] [CrossRef] [PubMed]
- Xie, J.; Xie, Q.; Zhang, H.; Ameres, S.L.; Hung, J.H.; Su, Q.; He, R.; Mu, X.; Seher Ahmed, S.; Park, S.; et al. MicroRNA-regulated, systemically delivered rAAV9: A step closer to CNS-restricted transgene expression. Mol. Ther. 2011, 19, 526–535. [Google Scholar] [CrossRef] [PubMed]
- Henderson, D.A. Smallpox eradication. Public Health Rep. 1980, 95, 422–426. [Google Scholar] [PubMed]
- Lauring, A.S.; Jones, J.O.; Andino, R. Rationalizing the development of live attenuated virus vaccines. Nat. Biotechnol. 2010, 28, 573–579. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215–233. [Google Scholar] [CrossRef] [PubMed]
- Gismondi, M.I.; Ortiz, X.P.; Curra, A.P.; Asurmendi, S.; Taboga, O. Artificial microRNAs as antiviral strategy to FMDV: Structural implications of target selection. J. Virol. Methods 2014, 199, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Brostoff, T.; Pesavento, P.A.; Barker, C.M.; Kenney, J.L.; Dietrich, E.A.; Duggal, N.K.; Bosco-Lauth, A.M.; Brault, A.C. MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice. Vaccine 2016, 34, 5366–5375. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sullivan, C.S.; Grundhoff, A.T.; Tevethia, S.; Pipas, J.M.; Ganem, D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005, 435, 682–686. [Google Scholar] [CrossRef] [PubMed]
- Umbach, J.L.; Kramer, M.F.; Jurak, I.; Karnowski, H.W.; Coen, D.M.; Cullen, B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454, 780–783. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gottwein, E.; Mukherjee, N.; Sachse, C.; Frenzel, C.; Majoros, W.H.; Chi, J.T.; Braich, R.; Manoharan, M.; Soutschek, J.; Ohler, U.; et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450, 1096–1099. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kincaid, R.P.; Burke, J.M.; Sullivan, C.S. RNA virus microRNA that mimics a B-cell oncomiR. Proc. Natl. Acad. Sci. USA 2012, 109, 3077–3082. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Burke, J.M.; Bass, C.R.; Kincaid, R.P.; Sullivan, C.S. Identification of tri-phosphatase activity in the biogenesis of retroviral microRNAs and RNAP III-generated shRNAs. Nucleic Acids Res. 2014, 42, 13949–13962. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Whisnant, A.W.; Kehl, T.; Bao, Q.; Materniak, M.; Kuzmak, J.; Lochelt, M.; Cullen, B.R. Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus. J. Virol. 2014, 88, 4679–4686. [Google Scholar] [CrossRef] [PubMed]
- Kincaid, R.P.; Chen, Y.; Cox, J.E.; Rethwilm, A.; Sullivan, C.S. Noncanonical microRNA (miRNA) biogenesis gives rise to retroviral mimics of lymphoproliferative and immunosuppressive host miRNAs. mBio 2014, 5, e00074. [Google Scholar] [CrossRef] [PubMed]
- Shapiro, J.S.; Langlois, R.A.; Pham, A.M.; tenOever, B.R. Evidence for a cytoplasmic microprocessor of pri-miRNAs. RNA 2012, 18, 1338–1346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Langlois, R.A.; Shapiro, J.S.; Pham, A.M.; tenOever, B.R. In vivo delivery of cytoplasmic RNA virus-derived miRNAs. Mol. Ther. 2012, 20, 367–375. [Google Scholar] [CrossRef] [PubMed]
- Rouha, H.; Thurner, C.; Mandl, C.W. Functional microRNA generated from a cytoplasmic RNA virus. Nucleic Acids Res. 2010, 38, 8328–8337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shapiro, J.S.; Varble, A.; Pham, A.M.; tenOever, B.R. Noncanonical cytoplasmic processing of viral microRNAs. RNA 2010, 16, 2068–2074. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Varble, A.; Chua, M.A.; Perez, J.T.; Manicassamy, B.; Garcia-Sastre, A.; tenOever, B.R. Engineered RNA viral synthesis of microRNAs. Proc. Natl. Acad. Sci. USA 2010, 107, 11519–11524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Benitez, A.A.; Spanko, L.A.; Bouhaddou, M.; Sachs, D.; tenOever, B.R. Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response. Cell Rep. 2015, 13, 1456–1466. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Arevalo, M.T.; Diaz-Arevalo, D.; Chen, Y.; Choi, J.G.; Zeng, M. Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA. J. Control. Release 2015, 207, 70–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Landgraf, P.; Rusu, M.; Sheridan, R.; Sewer, A.; Iovino, N.; Aravin, A.; Pfeffer, S.; Rice, A.; Kamphorst, A.O.; Landthaler, M.; et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129, 1401–1414. [Google Scholar] [CrossRef] [PubMed]
- Tsetsarkin, K.A.; Liu, G.; Kenney, H.; Hermance, M.; Thangamani, S.; Pletnev, A.G. Concurrent micro-RNA mediated silencing of tick-borne flavivirus replication in tick vector and in the brain of vertebrate host. Sci. Rep. 2016, 6, 33088. [Google Scholar] [CrossRef] [PubMed]
- Mullokandov, G.; Baccarini, A.; Ruzo, A.; Jayaprakash, A.D.; Tung, N.; Israelow, B.; Evans, M.J.; Sachidanandam, R.; Brown, B.D. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat. Methods 2012, 9, 840–846. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tenoever, B.R. RNA viruses and the host microRNA machinery. Nat. Rev. Microbiol. 2013, 11, 169–180. [Google Scholar] [CrossRef] [PubMed]
- Heiss, B.L.; Maximova, O.A.; Pletnev, A.G. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J. Virol. 2011, 85, 1464–1472. [Google Scholar] [CrossRef] [PubMed]
- Yen, L.C.; Lin, Y.L.; Sung, H.H.; Liao, J.T.; Tsao, C.H.; Su, C.M.; Lin, C.K.; Liao, C.L. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome. Vaccine 2013, 31, 5915–5922. [Google Scholar] [CrossRef] [PubMed]
- He, F.; Yao, H.; Wang, J.; Xiao, Z.; Xin, L.; Liu, Z.; Ma, X.; Sun, J.; Jin, Q.; Liu, Z. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice. J. Virol. 2015, 89, 908–916. [Google Scholar] [CrossRef] [PubMed]
- Fiege, J.K.; Langlois, R.A. Investigating influenza a virus infection: Tools to track infection and limit tropism. J. Virol. 2015, 89, 6167–6170. [Google Scholar] [CrossRef] [PubMed]
- Langlois, R.A.; Varble, A.; Chua, M.A.; Garcia-Sastre, A.; tenOever, B.R. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl. Acad. Sci. USA 2012, 109, 12117–12122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tsetsarkin, K.A.; Liu, G.; Kenney, H.; Bustos-Arriaga, J.; Hanson, C.T.; Whitehead, S.S.; Pletnev, A.G. Dual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses. PLoS Pathog. 2015, 11, e1004852. [Google Scholar] [CrossRef] [PubMed]
- Waring, B.M.; Sjaastad, L.E.; Fiege, J.K.; Fay, E.J.; Reyes, I.; Moriarity, B.; Langlois, R.A. MicroRNA-based attenuation of influenza virus across susceptible hosts. J. Virol. 2017, 92, e01741-17. [Google Scholar] [CrossRef]
- Perez, J.T.; Pham, A.M.; Lorini, M.H.; Chua, M.A.; Steel, J.; tenOever, B.R. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat. Biotechnol. 2009, 27, 572–576. [Google Scholar] [CrossRef] [PubMed]
- Langlois, R.A.; Albrecht, R.A.; Kimble, B.; Sutton, T.; Shapiro, J.S.; Finch, C.; Angel, M.; Chua, M.A.; Gonzalez-Reiche, A.S.; Xu, K.; et al. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat. Biotechnol. 2013, 31, 844–847. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vignuzzi, M.; Wendt, E.; Andino, R. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 2008, 14, 154–161. [Google Scholar] [CrossRef] [PubMed]
- Pham, A.M.; Langlois, R.A.; Tenoever, B.R. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog. 2012, 8, e1002465. [Google Scholar] [CrossRef] [PubMed]
- Tsetsarkin, K.A.; Liu, G.; Shen, K.; Pletnev, A.G. Kissing-loop interaction between 5′ and 3′ ends of tick-borne Langat virus genome ‘bridges the gap’ between mosquito- and tick-borne flaviviruses in mechanisms of viral RNA cyclization: Applications for virus attenuation and vaccine development. Nucleic Acids Res. 2016, 44, 3330–3350. [Google Scholar] [CrossRef] [PubMed]
- Tsetsarkin, K.A.; Liu, G.; Volkova, E.; Pletnev, A.G. Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development. mBio 2017, 8, e02326-16. [Google Scholar] [CrossRef] [PubMed]
- Woolaway, K.E.; Lazaridis, K.; Belsham, G.J.; Carter, M.J.; Roberts, L.O. The 5′ untranslated region of Rhopalosiphum padi virus contains an internal ribosome entry site which functions efficiently in mammalian, plant, and insect translation systems. J. Virol. 2001, 75, 10244–10249. [Google Scholar] [CrossRef] [PubMed]
- Chao, J.A.; Lee, J.H.; Chapados, B.R.; Debler, E.W.; Schneemann, A.; Williamson, J.R. Dual modes of RNA-silencing suppression by Flock House virus protein B2. Nat. Struct. Mol. Biol. 2005, 12, 952–957. [Google Scholar] [CrossRef] [PubMed]
- Van Rij, R.P.; Saleh, M.C.; Berry, B.; Foo, C.; Houk, A.; Antoniewski, C.; Andino, R. The RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogaster. Genes Dev. 2006, 20, 2985–2995. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nayak, A.; Berry, B.; Tassetto, M.; Kunitomi, M.; Acevedo, A.; Deng, C.; Krutchinsky, A.; Gross, J.; Antoniewski, C.; Andino, R. Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila. Nat. Struct. Mol. Biol. 2010, 17, 547–554. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Qi, N.; Zhang, L.; Qiu, Y.; Wang, Z.; Si, J.; Liu, Y.; Xiang, X.; Xie, J.; Qin, C.F.; Zhou, X.; et al. Targeting of dicer-2 and RNA by a viral RNA silencing suppressor in Drosophila cells. J. Virol. 2012, 86, 5763–5773. [Google Scholar] [CrossRef] [PubMed]
- van Mierlo, J.T.; Bronkhorst, A.W.; Overheul, G.J.; Sadanandan, S.A.; Ekstrom, J.O.; Heestermans, M.; Hultmark, D.; Antoniewski, C.; van Rij, R.P. Convergent evolution of argonaute-2 slicer antagonism in two distinct insect RNA viruses. PLoS Pathog. 2012, 8, e1002872. [Google Scholar] [CrossRef] [PubMed]
- Blair, C.D. Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission. Future Microbiol. 2011, 6, 265–277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brackney, D.E.; Beane, J.E.; Ebel, G.D. RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog. 2009, 5, e1000502. [Google Scholar] [CrossRef] [PubMed]
- Backes, S.; Shapiro, J.S.; Sabin, L.R.; Pham, A.M.; Reyes, I.; Moss, B.; Cherry, S.; tenOever, B.R. Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell Host Microbe 2012, 12, 200–210. [Google Scholar] [CrossRef] [PubMed]
- Lu, S.; Cullen, B.R. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. J. Virol. 2004, 78, 12868–12876. [Google Scholar] [CrossRef] [PubMed]
- Li, H.; Bradley, K.C.; Long, J.S.; Frise, R.; Ashcroft, J.W.; Hartgroves, L.C.; Shelton, H.; Makris, S.; Johansson, C.; Cao, B.; et al. Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. PLoS Pathog. 2018, 14, e1006821. [Google Scholar] [CrossRef] [PubMed]
- Tundup, S.; Kandasamy, M.; Perez, J.T.; Mena, N.; Steel, J.; Nagy, T.; Albrecht, R.A.; Manicassamy, B. Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species. PLoS Pathog. 2017, 13, e1006270. [Google Scholar] [CrossRef] [PubMed]
- Seo, G.J.; Kincaid, R.P.; Phanaksri, T.; Burke, J.M.; Pare, J.M.; Cox, J.E.; Hsiang, T.Y.; Krug, R.M.; Sullivan, C.S. Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 2013, 14, 435–445. [Google Scholar] [CrossRef] [PubMed]
- Bogerd, H.P.; Whisnant, A.W.; Kennedy, E.M.; Flores, O.; Cullen, B.R. Derivation and characterization of Dicer- and microRNA-deficient human cells. RNA 2014, 20, 923–937. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Backes, S.; Langlois, R.A.; Schmid, S.; Varble, A.; Shim, J.V.; Sachs, D.; Tenoever, B.R. The Mammalian response to virus infection is independent of small RNA silencing. Cell Rep. 2014, 8, 114–125. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fay, E.J.; Langlois, R.A. MicroRNA-Attenuated Virus Vaccines. Non-Coding RNA 2018, 4, 25. https://doi.org/10.3390/ncrna4040025
Fay EJ, Langlois RA. MicroRNA-Attenuated Virus Vaccines. Non-Coding RNA. 2018; 4(4):25. https://doi.org/10.3390/ncrna4040025
Chicago/Turabian StyleFay, Elizabeth J., and Ryan A. Langlois. 2018. "MicroRNA-Attenuated Virus Vaccines" Non-Coding RNA 4, no. 4: 25. https://doi.org/10.3390/ncrna4040025